Cargando…

Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai

BACKGROUND: Treatment of multidrug-resistant tuberculosis (MDR-TB) in the Programmatic Management of Drug-resistant TB program involves a standard regimen with a 6-month intensive phase and an 18-month continuation phase. However, the local drug resistance patterns in high MDR regions such as Mumbai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Udwadia, Zarir F, Mullerpattan, Jai Bharat, Shah, Kushal D, Rodrigues, Camilla S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857559/ https://www.ncbi.nlm.nih.gov/pubmed/27185987 http://dx.doi.org/10.4103/0970-2113.180800

Ejemplares similares

Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic
por: Udwadia, Zarir F., et al.
Publicado: (2021)

Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
por: Udwadia, Zarir F., et al.
Publicado: (2014)

Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India
por: Resendiz-Galvan, Juan Eduardo, et al.
Publicado: (2023)

Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic
por: Udwadia, Zarir F., et al.
Publicado: (2019)

Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India
por: Tornheim, Jeffrey A, et al.
Publicado: (2021)

Tropical pulmonary eosinophilia - A review
por: Mullerpattan, Jai B., et al.
Publicado: (2013)

Who will teach the teachers: An analysis of the inhaler technique of Indian patients and health care providers in a tertiary health care centre
por: Mullerpattan, Jai Bharat, et al.
Publicado: (2016)

Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis
por: Tornheim, Jeffrey A., et al.
Publicado: (2022)

Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades?
por: Udwadia, Zarir F., et al.
Publicado: (2010)

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis
por: Udwadia, Zarir F., et al.
Publicado: (2015)

Use of nintedanib in patients with idiopathic pulmonary fibrosis: Initial Indian experience
por: Mullerpattan, Jai B, et al.
Publicado: (2019)

Clinical features associated with linezolid resistance among multidrug resistant tuberculosis patients at a tertiary care hospital in Mumbai, India
por: Tornheim, J.A., et al.
Publicado: (2020)

Children and Multidrug-Resistant Tuberculosis in Mumbai (Bombay), India
por: Karande, Sunil, et al.
Publicado: (2002)

Profile of HIV and multidrug-resistant tuberculosis in orphans living in orphanages in Mumbai, Maharashtra, India
por: Shah, Ira, et al.
Publicado: (2020)

India should speed up access to bedaquiline-based all-oral regimens, not procrastinate further
por: Udwadia, Zarir F, et al.
Publicado: (2021)

Clonal Population of Mycobacterium tuberculosis Strains Reside within Multiple Lung Cavities
por: Vadwai, Viral, et al.
Publicado: (2011)

Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Greater Metropolitan Mumbai: Trends over Time
por: Dalal, Alpa, et al.
Publicado: (2015)

Quality of drug-resistant tuberculosis care: Gaps and solutions
por: Udwadia, Zarir, et al.
Publicado: (2019)

Disseminated tuberculosis with immune thrombocytopenic purpura
por: Dagaonkar, Rucha S., et al.
Publicado: (2012)

Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis
por: Jain, Kalpesh, et al.
Publicado: (2014)

Bronchoalveolar lavage contamination by sterile containers: A unique and unrecognized cause of a false-positive galactomannan
por: Kathar, Sushil Shriram, et al.
Publicado: (2017)

Tuberculosis in South Asia: a tide in the affairs of men
por: Basnyat, Buddha, et al.
Publicado: (2018)

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
por: Dreyer, Viola, et al.
Publicado: (2022)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
por: Maryandyshev, Andrey, et al.
Publicado: (2017)

What’s Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2019)

High Rate of Hypothyroidism in Multidrug-Resistant Tuberculosis Patients Co-Infected with HIV in Mumbai, India
por: Andries, Aristomo, et al.
Publicado: (2013)

Optimal management of drug-resistant tuberculosis: Can India lead the way?
por: Masini, Tiziana, et al.
Publicado: (2023)

Protocol for a case–control study of vitamin D status, adult multidrug-resistant tuberculosis disease and tuberculosis infection in Mumbai, India
por: Mistry, Nerges, et al.
Publicado: (2020)

Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment?
por: Pinto, Lancelot M, et al.
Publicado: (2010)

Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients
por: Sharma, Surendra K., et al.
Publicado: (2011)

Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care centre in Mumbai, India
por: Nambiar, Remya, et al.
Publicado: (2021)

Effectiveness of the Standard WHO Recommended Retreatment Regimen (Category II) for Tuberculosis in Kampala, Uganda: A Prospective Cohort Study
por: Jones-López, Edward C., et al.
Publicado: (2011)

Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres
por: Riccardi, Niccolò, et al.
Publicado: (2019)

Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India
por: Isaakidis, Petros, et al.
Publicado: (2013)

Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India
por: Isaakidis, Petros, et al.
Publicado: (2012)

Oxaliplatin-induced lung fibrosis
por: Shah, Arpan, et al.
Publicado: (2009)

Swimming against the STREAM: Why STREAM 2 data cannot be easily applied to MDR-TB patients across India
por: Udwadia, Zarir F., et al.
Publicado: (2023)

Alarming Levels of Drug-Resistant Tuberculosis in HIV-Infected Patients in Metropolitan Mumbai, India
por: Isaakidis, Petros, et al.
Publicado: (2014)

A systematic review of clinical outcomes on the WHO Category II retreatment regimen for tuberculosis
por: Cohen, D. B., et al.
Publicado: (2018)

Is Scale-Up of Community Mobilisation among Sex Workers Really Possible in Complex Urban Environments? The Case of Mumbai, India
por: Kongelf, Anine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s6kfr368qit032qpnuajvk732t